SCHEMBL10187338

SCHEMBL10187338

CCCNc1cc(N)ncn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM2 P50570 2/20 0.45
AURKA O14965 1/20 0.42
HRH4 Q9H3N8 2/20 0.40
ALDH1A1 P00352 1/20 0.40
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
CCNA2 P20248 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39
CDK5 Q00535 1/20 0.39
CDK5R1 Q15078 1/20 0.39
HTT P42858 2/20 0.38
CCNC P24863 1/20 0.38
CDK8 P49336 1/20 0.38
EGFR P00533 2/20 0.38
TLR8 Q9NR97 2/20 0.38
SCN9A Q15858 1/20 0.37
KDR P35968 1/20 0.37
CHEK1 O14757 1/20 0.37
ESR1 P03372 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18636563 0.89 DNM2 (0.54) DNM2AURKAHRH4CDK1CCNB1
SCHEMBL17103026 0.87 DNM2 (0.60) DNM2AURKAALDH1A1CDK1CCNB1
SCHEMBL10188164 0.84 EGFR (0.49) DNM2AURKAHRH4CDK1CCNB1
SCHEMBL29402899 0.81 EGFR (0.51) AURKAHRH4ALDH1A1CDK1CCNB1
SCHEMBL807297 0.81 EGFR (0.51) AURKAHRH4ALDH1A1CDK1CCNB1
SCHEMBL18636555 0.80 HRH4 (0.54) DNM2AURKAHRH4CDK1CCNB1
SCHEMBL20929509 0.80 CYP1A2 (0.54) AURKAALDH1A1HTTSCN9AHCAR3
SCHEMBL30138398 0.80 CYP1A2 (0.54) AURKAALDH1A1HTTSCN9AHCAR3
SCHEMBL13467358 0.79 HRH4 (0.40) DNM2AURKAHRH4ALDH1A1CDK1
SCHEMBL2231653 0.79 DNM2 (0.48) DNM2AURKAKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758892-B1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2012-10-17 EP disclosed
WO-2012001107-A1 PIPERIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-01-05 WO disclosed